Retrieve Medical Holdings, Inc. (RMHI) EBIT (2011 - 2022)

Retrieve Medical Holdings (RMHI) reported EBIT of -$110412.0 for Q4 2022, down 112.07% year-over-year from $914473.4 in Q4 2021, and down 109.96% quarter-over-quarter from -$52587.0 in Q3 2022.

Retrieve Medical Holdings, Inc. (RMHI) EBIT (2011 - 2022) Analysis & Trends

Retrieve Medical Holdings (RMHI) has 12 years of EBIT data on file, last reported at -$110412.0 in Q4 2022.

  • EBIT for Q4 2022 came in at -$110412.0, down 112.07% year-over-year; the trailing twelve-month figure through Dec 2022 was -$221651.0 (down 91.39% YoY), and the FY2022 annual result was -$163302.0, down 137.63% from the prior year.
  • EBIT retreated to -$110412.0 in Q4 2022 per RMHI's latest filing, from -$52587.0 in the prior quarter.
  • Over five years, EBIT peaked at -$953.0 in Q4 2018 and troughed at -$110412.0 in Q4 2022.
  • A 5-year average of -$18722.6 and a median of -$4316.5 in 2020 frame the typical range for EBIT.
  • The sharpest annual moves came in 2018 and 2021: EBIT surged 86.43% in 2018, then sank 3592.83% in 2021.
  • A 5-year view of EBIT shows it stood at -$953.0 in 2018, then declined by 19.41% to -$1138.0 in 2019, then slumped by 336.91% to -$4972.0 in 2020, then tumbled by 947.12% to -$52063.0 in 2021, then sank by 112.07% to -$110412.0 in 2022.
  • Business Quant data shows RMHI's EBIT at -$110412.0 in Q4 2022, -$52587.0 in Q3 2022, and -$12091.0 in Q2 2022.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2022 -110,412.00
Sep 30, 2022 -52,587.00
Jun 30, 2022 -12,091.00
Mar 31, 2022 -46,561.00
Dec 31, 2021 -52,063.00
Sep 30, 2021 -3,661.00
Jun 30, 2021 -16,845.00
Mar 31, 2021 -43,243.00
Dec 31, 2020 -4,972.00
Sep 30, 2020 -2,022.00
Jun 30, 2020 -1,204.00
Mar 31, 2020 -1,171.00
Dec 31, 2019 -1,138.00
Sep 30, 2019 -1,475.00
Jun 30, 2019 -1,483.00
Mar 31, 2019 -1,773.00
Dec 31, 2018 -953.00
Sep 30, 2018 -9,615.00
Jun 30, 2018 -2,998.00
Mar 31, 2018 -8,185.00